These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 4931261)

  • 1. Relationship between the hospital milieu and the response to phenothiazines in the treatment of schizophrenics.
    Klerman GL; Goldberg SG; Davis D
    Acta Psychiatr Belg; 1970 Nov; 70(6):716-29. PubMed ID: 4931261
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
    Tetreault L
    Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
    [No Abstract]   [Full Text] [Related]  

  • 3. Schizophrenic subtypes defined by response to drugs and placebo.
    Goldberg SC; Mattsson NB
    Dis Nerv Syst; 1968 May; 29(5):Suppl:153-8. PubMed ID: 4876985
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
    Kiev A; Güclü B; Kulkarni AS
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
    [No Abstract]   [Full Text] [Related]  

  • 5. [Psychopharmacologic contribution to the clinical use of a psychosedative].
    Pernhaupt G; Quatember R
    Wien Med Wochenschr; 1970 Oct; 120(42):737-40. PubMed ID: 4926115
    [No Abstract]   [Full Text] [Related]  

  • 6. A controlled study of mesoridazine: an effective treatment for schizophrenia.
    McIndoo MV
    South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
    [No Abstract]   [Full Text] [Related]  

  • 7. A preliminary study of SKF-14,336 in chronic schizophrenia.
    Simpson GM; Iqbal J; Iqbal F
    Curr Ther Res Clin Exp; 1966 Sep; 8(9):447-51. PubMed ID: 4957931
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia.
    Gershon S; Hekimian LJ; Burdock EI; Park S; Floyd A
    Curr Ther Res Clin Exp; 1970 Dec; 12(12):810-8. PubMed ID: 4396420
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of butaperazine and prochlorperazine for schizophrenia in acute phase].
    Albert JM; Rajotte P; Rajotte E; Tétreault L
    Union Med Can; 1970 Jul; 99(7):1282-5. PubMed ID: 4396306
    [No Abstract]   [Full Text] [Related]  

  • 10. Butaperazine (Repoise).
    Med Lett Drugs Ther; 1968 Nov; 10(22):89-90. PubMed ID: 4389275
    [No Abstract]   [Full Text] [Related]  

  • 11. The neuroleptics. 10. Therapeutic problems.
    Barahona-Fernandes HJ; Cazzullo CL; Cocchi A; Denber HC; Freyhan FA; Klerman GL; Köknel O; Levine J; Saarma J; Sarteschi P; Vinar O; Wittenborn JR
    Mod Probl Pharmacopsychiatry; 1970; 5():148-56. PubMed ID: 4949818
    [No Abstract]   [Full Text] [Related]  

  • 12. [The adrenalin-histamine skin test in schizophrenics under drug therapy].
    Koptagel G
    Arch Psychiatr Nervenkr (1970); 1967; 209(1):38-52. PubMed ID: 4382736
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
    Freeman H; Oktem MR; Oktem N
    Curr Ther Res Clin Exp; 1969 May; 11(5):263-70. PubMed ID: 4977397
    [No Abstract]   [Full Text] [Related]  

  • 14. Differences in clinical effects of three phenothiazines in "acute" schizophrenia.
    Dis Nerv Syst; 1967 Jun; 28(6):369-83. PubMed ID: 5342391
    [No Abstract]   [Full Text] [Related]  

  • 15. Two studies of the effects of mesoridazine.
    Ritter RM; Tatum PA
    J Clin Pharmacol New Drugs; 1972; 12(8):349-55. PubMed ID: 4560030
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent developments in the drug treatment of schizophrenia.
    Davis JM
    Am J Psychiatry; 1976 Feb; 133(2):208-14. PubMed ID: 766652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A few remarks on the use of neuroleptics with schizophrenics].
    Ostaptzeff G; Ostaptzeff-Lavoine
    Ann Med Psychol (Paris); 1968 Oct; 2(3):388-91. PubMed ID: 4387035
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic results and complications in the use of lyogen in long-term schizophrenics].
    Kutsenok BM; Zolotnitskiĭ RI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(10):1578-83. PubMed ID: 5490156
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mesoridazine, a new medium tranquilizing agent in internal medicine].
    Rummelhardt K
    Wien Med Wochenschr; 1967 May; 117(21):542-4. PubMed ID: 4869522
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of Tybamate in chronic schizophrenia. (Minor tranquilizers as adjunct therapy in psychosis).
    Serafetinides EA; Clark ML
    Dis Nerv Syst; 1971 Aug; 32(8):567-71. PubMed ID: 5094163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.